Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Michonneau

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 6, 2025
Transfusion strategy and allo-immunization to red blood cell antigens after allogeneic hematopoietic stem cell transplantation with partial donor/recipient Rh matchingJeromine Beaufort, Alienor Xhaard, Aline Floch, et al.
Transplantation and Cellular Therapy|March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host DiseaseDaniel Wolff, Carlos Solano, David Michonneau, et al.
Haematologica|August 1, 2020
Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantationPierre-Edouard Debureaux, Pierre Bourrier, Pierre-Emmanuel Rautou, et al.
Blood|August 19, 2022
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantationNicolas Vallet, Sophie Le Grand, Louise Bondeelle, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Nature Communications|November 9, 2021
Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunctionBaptiste Lamarthée, Armance Marchal, Soëli Charbonnier, et al.
European Journal of Preventive Cardiology|September 30, 2025
Predicting cardiovascular events in allogeneic hematopoietic stem cell transplant recipientsBenjamin Sibilia, Trecy Gonçalves, Florian Chevillon, et al.
Haematologica|January 18, 2020
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working PartyJoerg Henes, Maria Carolina Oliveira, Myriam Labopin, et al.
Blood|January 22, 2015
CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host diseaseAdèle de Masson, Jean-David Bouaziz, Hélène Le Buanec, et al.
The Canadian Journal of Cardiology|March 25, 2026
Risk of Post-Transplant Cyclophosphamide-Related Cardiotoxicity in Allogeneic Stem Cell TransplantationRayane Hadjali, Florian Chevillon, Benjamin Sibilia, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 6, 2025
Transfusion strategy and allo-immunization to red blood cell antigens after allogeneic hematopoietic stem cell transplantation with partial donor/recipient Rh matchingJeromine Beaufort, Alienor Xhaard, Aline Floch, et al.
Transplantation and Cellular Therapy|March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host DiseaseDaniel Wolff, Carlos Solano, David Michonneau, et al.
Haematologica|August 1, 2020
Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantationPierre-Edouard Debureaux, Pierre Bourrier, Pierre-Emmanuel Rautou, et al.
Blood|August 19, 2022
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantationNicolas Vallet, Sophie Le Grand, Louise Bondeelle, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Nature Communications|November 9, 2021
Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunctionBaptiste Lamarthée, Armance Marchal, Soëli Charbonnier, et al.
European Journal of Preventive Cardiology|September 30, 2025
Predicting cardiovascular events in allogeneic hematopoietic stem cell transplant recipientsBenjamin Sibilia, Trecy Gonçalves, Florian Chevillon, et al.
Haematologica|January 18, 2020
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working PartyJoerg Henes, Maria Carolina Oliveira, Myriam Labopin, et al.
Blood|January 22, 2015
CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host diseaseAdèle de Masson, Jean-David Bouaziz, Hélène Le Buanec, et al.
The Canadian Journal of Cardiology|March 25, 2026
Risk of Post-Transplant Cyclophosphamide-Related Cardiotoxicity in Allogeneic Stem Cell TransplantationRayane Hadjali, Florian Chevillon, Benjamin Sibilia, et al.
Pageof 11